Marking World Hypertension Day, the Union Ministry of Health and Family Welfare launched a landmark nationwide initiative aimed at strengthening India’s response to non communicable diseases (NCDs). Under the ambitious “75/25” initiative, the Government plans to place 75 million individuals suffering from hypertension and diabetes
New Delhi — In a significant development for India’s healthcare policy landscape, M. Srinivas, Director of All India Institute of Medical Sciences Delhi, has been appointed as a Member of NITI Aayog. He succeeds V. K. Paul, marking a notable transition in leadership at the
In a visionary move toward transforming India’s emergency medical response, Dr. V.K. Paul, Member (Health), NITI Aayog, has called for a technology-driven overhaul of the national ambulance network to ensure that emergency medical care reaches patients within 10 minutes. Speaking at a high-level health forum, Dr.
The hospital’s M-NICU marks the first of its kind in a private set-up amid the Indian healthcare ecosystem, with special focus on Kangaroo Mother Care and immediate skin-to-skin contact after birth Amrita Hospital, Faridabad, which is India’s largest private multi-speciality healthcare institution, has launched a Mother-Neonatal
Government of India has formulated a scheme namely “Promotion of Research and Innovation in Pharma MedTech Sector” The industry, academia and policy makers need to work together to create a future-ready workforce Policymakers and Industry Experts advocate closer collaboration and partnerships between Industry and Academia in MedTech Sector Visit of G-20 delegates at
Gujarat is committed to provide support to MedTech & pharma industry; urges investment by industry: Bhupendrabhai Patel GANDHINAGAR, 17 August 2023: Dr Mansukh Mandaviya, Minister for Health & Family Welfare and Chemicals & Fertilizers, Govt of India inaugurated India’s 1st ever MedTech Expo organized by the Department of Pharmaceuticals, Government
Following an inspection of the Bharat Biotech premises on 14 March for Covaxin's EUL, WHO announced the suspension of the vaccine's supply owing to deficiencies in good manufacturing practices Weeks after WHO suspended the supply of Covaxin through UN procurement agencies, the MEA suggested that vaccine-maker
Union Fisheries, Animal Husbandry, and Dairying Minister, Mr. Parshottam Rupala lauded the efforts of Indian Immunologicals Limited (IIL) for their ability to roll out Covid-19 vaccine drug substance in record time. Indian Immunologicals Ltd (IIL) has quickly responded to the nation’s call and the request of the
